Status:

COMPLETED

Effect of Gastric Bypass on Patients With Type 2 Diabetes and/or Dyslipidemia

Lead Sponsor:

Vanderbilt University

Conditions:

Type 2 Diabetes

Eligibility:

All Genders

17-66 years

Brief Summary

This is a retrospective review of patients who have undergone bariatric surgery at VUMC and who have type 2 Diabetes and/or dyslipidemia. The investigators have previously found that gastric bypass si...

Detailed Description

Review and record changes in the subject's medication. subjects vitals: weight, blood pressure, and fasting blood values, which include: * HbA1c * Fasting blood glucose * Fasting Insulin * Lipid Pane...

Eligibility Criteria

Inclusion

  • Patients who have had diabetes and/or dyslipidemia prior to gastric by-pass. -

Exclusion

  • Patients who have had type 2 diabetes that was diet controlled at time of surgery; and debilitated patients who are unable to come in for a physical exam.
  • \-

Key Trial Info

Start Date :

November 1 1999

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

November 1 2007

Estimated Enrollment :

219 Patients enrolled

Trial Details

Trial ID

NCT00879125

Start Date

November 1 1999

End Date

November 1 2007

Last Update

September 14 2009

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Vanderbilt University Medical Center

Nashville, Tennessee, United States, 37232

Effect of Gastric Bypass on Patients With Type 2 Diabetes and/or Dyslipidemia | DecenTrialz